In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis

Arriaga, J. M., Ronaldson-Bouchard, K., Picech, F., Nunes de Almeida, F., Afari, S., Chhouri, H., Vunjak-Novakovic, G., & Abate-Shen, C. (2024). In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene, 43(17), 1303–1315. https://doi.org/10.1038/s41388-024-02995-5
Authors:
Juan M Arriaga
Kacey Ronaldson-Bouchard
Florencia Picech
Francisca Nunes de Almeida
Stephanie Afari
Houssein Chhouri
Gordana Vunjak-Novakovic
Cory Abate-Shen
Affiliated Authors:
Juan M Arriaga
Kacey Ronaldson-Bouchard
Florencia Picech
Francisca Nunes de Almeida
Stephanie Afari
Gordana Vunjak-Novakovic
Cory Abate-Shen
Publication Type:
Article
Unique ID:
10.1038/s41388-024-02995-5
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: